Investor Relations Forum (EXL)
Event on 2017-09-07 08:00:00
Investor Relations Forum
Having a good product today isn’t enough to attract investment opportunities; you must have the ability to demonstrate a market for the product you are developing. IR departments deliver a channel through which the investment community can effortlessly access information about the company. This is particularly important for information transparency and for promoting a sense of integrity and trustworthiness on the part of the company.
The Investor Relations Forum, taking place on September 7-8, 2017 in Boston, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations, advancements in technology, more engaged investors and working relationships with advisory boards. Through this event IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. At this breakthrough two-day conference we will provide our attendees with the solutions to the unique set of challenges IR teams encounter and enable them to be more effective in their jobs.
Top Five Reasons to Attend
Learn crisis communication specific to the life sciences industry
Understand the best methods for dealing with the trials and distresses of an activist shareholder
Address investor relation’s involvement in successful mergers and acquisitions
Tackle the power of social media in 2017 and how it drives stock
Examine the different interests of numerous shareholders that are geographically dispersed
Who Should Attend
This event is also of interest to:
Proxy Solicitation and Corporate Advisory Firms
Corporate Access Platform Providers
The agenda for the Investor Relations Forum is currently under development. Topics under consideration include:
Understanding your shareholders and their changing interests
Understand the different interests of numerous shareholders that are geographically dispersed
Address shareholder views that are not consistent
Working with the C-suite
Manage the resources of the C-suite to maximize the overall return on investment of its financial communications outreach
Learn to explain what the investment community measures, what they are most interested in, their criticisms and the areas of the business where you think the company is least understood
Stay in close touch with Wall Street, and ensuring the C-suite is available for investors on a regular basis
Learn how to get invited to “the C-suite table”
Addressing “value gap” issues
Discuss the dialogue that focuses on identifying gaps in perspectives on fundamentals and opportunity sets and discussing them directly, in a fact-based, well-supported manner
Conduct proactive outreach to stakeholders when information from Wall Street isn’t clear
Point investors toward promising areas but not crossing the material disclosure line
Learn how IROs can be more proactive to help inform better “Street” estimates
Managing technology in the financial world
Discuss how Twitter and other social media platforms are affecting trading
Learn how investors are using big data to pick stock
Understand how companies are leveraging technology in new ways to improve performance, leverage productivity and rethink how they run an IR program
Discover how your peers in investor relations use new technology and address competitive intelligence
Find out how investors are incorporating big data into fund management and the new ways analysts are assessing info about their company from third-party sources
Benchmark your IR website and yield concrete ideas for how to improve it, particularly in respect to innovative online content and design and shareholder tools, on both desktop and mobile devices
Disclosing bad news
Be very clear with investors about what happened, why it happened and how you are addressing the issue
Build investor confidence — let them know management has a team and a plan to get things back on track
Make sure that message is consistent across all the audiences you’re trying to address and be aware of prior public commentary
Dealing with activist investors
Discover the latest trends and developments in activism
Learn to create a team to deal with hedge fund activism:
A small group of key officers
An investment banker
A proxy soliciting firm
A public relations firm
Assess exposure to an activist attack
Perform a candid assessment of shareholder sentiment, which should be appropriately communicated to senior management, and provide periodic briefings to the board
Ensure that company boards understand the tactics of activist investors and have a game plan for responding
Create long-term value under the pressure of short-term investor priorities
Explore how to promote the long-term success of a company while also acting to increased pressure to short-term priorities
Learn how can IROs can manage investors who plan for short-term results
MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.
PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment.
pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.
Visit pharmaphorum today to share, discuss and debate: www.pharmaphorum.com
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas.
Please contact the event manager Marilyn below for the following:
– Discounts for registering 5 or more participants.
– If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.
at The Revere Hotel Boston Common
200 Stuart Street
Boston, United States